Literature DB >> 11001079

The role of anti-epithelial cell antibodies in the pathogenesis of bilateral radiation pneumonitis caused by unilateral thoracic irradiation.

J Fujita1, S Bandoh, Y Ohtsuki, N Dobashi, M Hiroi, T Takeuchi, Y Fukunaga, H Miyaue, S Onishi, T Ishida, J Takahara.   

Abstract

Two cases of bilateral radiation pneumonitis associated with unilateral thoracic irradiation against lung cancer are described. Both patients died of respiratory failure and autopsy was performed. Histologically, bilateral diffuse alveolar damage was demonstrated in both cases, associated with marked organization of hyaline membrane in one case (case 1). In addition, numerous hyperplastic type II pneumocytes which strongly expressed cytokeratins 8, 18 and 19 were observed. In both patients' sera, antibodies against cytokeratin 8, 18 and 19 were demonstrated by a Western immunoblot. The possible association between autoantibodies to cytokeratins and diffuse alveolar damage observed in patients with bilateral radiation pneumonitis are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11001079     DOI: 10.1053/rmed.2000.0858

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  3 in total

1.  Bronchiolitis obliterans organising pneumonia: a consequence of breast radiotherapy.

Authors:  Ahmed Fahim; Anne P Campbell; Simon Paul Hart
Journal:  BMJ Case Rep       Date:  2012-01-18

2.  Idiopathic pulmonary fibrosis is associated with circulating antiepithelial antibodies.

Authors:  Ahmed Fahim; Mei C Chong; Michael G Crooks; Simon P Hart
Journal:  Lung       Date:  2012-05-16       Impact factor: 2.584

3.  Analysis of Clinical and Dosimetric Factors Influencing Radiation-Induced Lung Injury in Patients with Lung Cancer.

Authors:  Shuiyun Han; Feiying Gu; Gang Lin; Xiaojiang Sun; Yuezhen Wang; Zhun Wang; Qingren Lin; Denghu Weng; Yaping Xu; Weimin Mao
Journal:  J Cancer       Date:  2015-09-15       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.